Shigetada Furukawa
Impact in
- Physiology top 0.5%
- Adipose Tissue and Metabolism
- Diet and metabolism studies
- Biochemistry top 1%
- Antioxidant Activity and Oxidative Stress
Papers in
-
- Histone Deacetylase Inhibitors Research 4
- Glycosylation and Glycoproteins Research 2
-
- Adipose Tissue and Metabolism 4
- Co-authors
- Morihiro Matsuda (4 shared papers)Iichiro Shimomura (4 shared papers)Osamu Nakayama (4 shared papers)Takuya Fujita (3 shared papers)Masanori Iwaki (2 shared papers)Makoto Makishima (2 shared papers)Yukio Yamada (2 shared papers)Michio Shimabukuro (2 shared papers)
- Journals
- The Journal of Antibiotics (8 papers)European Journal of Pharmacology (3 papers)Journal of Clinical Investigation (2 papers)Biochemical and Biophysical Research Communications (1 paper)European Journal of Immunology (1 paper)
- Partner nations
- Japan
In The Last Decade
Shigetada Furukawa
21 papers receiving 6.2k citations
Shigetada Furukawa's Hit Papers
Peers
Comparison fields: 5 of 129
- Physiology 2.2k
- Biochemistry 467
- Epidemiology 1.9k
- Endocrinology, Diabetes and Metabolism 731
- Endocrine and Autonomic Systems 289
Countries citing papers authored by Shigetada Furukawa
This map shows the geographic impact of Shigetada Furukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigetada Furukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigetada Furukawa more than expected).
Fields of papers citing papers by Shigetada Furukawa
This network shows the impact of papers produced by Shigetada Furukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigetada Furukawa. The network helps show where Shigetada Furukawa may publish in the future.
Co-authors
The 25 scholars most cited alongside Shigetada Furukawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Increased oxidative stress in obesity and its impact on metabolic syndrome Hit paper breakdown → | 2004 | 4485 |
| 2 | Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation Hit paper breakdown → | 2007 | 1020 |
| 3 | 2004 | 406 | |
| 4 | 2003 | 218 | |
| 5 | 2016 | 73 | |
| 6 | 2016 | 64 | |
| 7 | 2003 | 42 | |
| 8 | FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC) II. Biological activities in animal models. | 2003 | 39 |
| 9 | 2005 | 18 | |
| 10 | 2018 | 17 | |
| 11 | 2001 | 16 | |
| 12 | 2005 | 11 | |
| 13 | 2006 | 10 | |
| 14 | 2000 | 10 | |
| 15 | 2005 | 10 | |
| 16 | 1997 | 8 | |
| 17 | 2011 | 5 | |
| 18 | 2018 | 4 | |
| 19 | 2003 | 4 | |
| 20 | 2018 | 4 |
About Shigetada Furukawa
Shigetada Furukawa is a scholar working on Molecular Biology, Physiology, Organic Chemistry, Pharmacology and Dermatology, having authored 21 papers that have together received 6.5k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Dermatology and Skin Diseases (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Microbial Natural Products and Biosynthesis (3 papers), Glycosylation and Glycoproteins Research (2 papers), Antifungal resistance and susceptibility (2 papers) and Transgenic Plants and Applications (2 papers). The work is most often cited by research in Physiology (2.2k citations), Biochemistry (467 citations), Epidemiology (1.9k citations), Endocrinology, Diabetes and Metabolism (731 citations) and Endocrine and Autonomic Systems (289 citations). Shigetada Furukawa has collaborated with scholars based in Japan. Frequent co-authors include Morihiro Matsuda, Iichiro Shimomura, Osamu Nakayama, Takuya Fujita, Masanori Iwaki, Makoto Makishima, Yukio Yamada, Michio Shimabukuro, Sachiyo Tanaka and Yugo Miyata. Their work appears in journals such as The Journal of Antibiotics, European Journal of Pharmacology, Journal of Clinical Investigation, Biochemical and Biophysical Research Communications and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.